Loading...
Please wait, while we are loading the content...
Similar Documents
Les mirages des nouveaux anticoagulants oraux
| Content Provider | Semantic Scholar |
|---|---|
| Author | Larock, Anne-Sophie Mullier, François Laloux, Patrice Douxfils, Jonathan Dogné, Jean-Michel Spinewine, Anne |
| Copyright Year | 2014 |
| Abstract | Son traitement a domicile dans le dossier medical comporte : Pradaxa® (dabigatran etexilate) 110mg 2x/j, Asaflow® (acide acetylsalicylique) 80mg 1x/j, Bisoprolol® 2.5mg 1x/j, Belsar plus® (olmesartan + hydrochlorothiazide) 20/12.5mg 1x/j, Uni Diamicron® (gliclazide) 60mg 1x/j, Zocor® (simvastatine) 20mg 1x/j, Stilnoct® (zolpidem) 10mg 1x/j, Lasix® (furosemide) 40mg 1⁄2 comp/j, Lysanxia® (prazepam) 10mg et Dafalgan® (paracetamol) 1g si necessaire. |
| Starting Page | 38 |
| Ending Page | 41 |
| Page Count | 4 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | https://cdn.uclouvain.be/public/Exports%20reddot/ir-ldri/images/Larock-JPB2014.pdf |
| Alternate Webpage(s) | http://www.farm.ucl.ac.be/cfcl/Full-papers-cfcl/Larock-2014-1.pdf |
| Volume Number | 96 |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |